{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:59:27Z","timestamp":1785473967527,"version":"3.56.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Consolidation osimertinib after concurrent chemoradiation is a standard treatment for unresectable stage III\n                      <jats:italic>EGFR<\/jats:italic>\n                      -mutated NSCLC, but endobronchial toxicity has not been well described. To our knowledge, this is the first reported case of collagenous endobronchial obliteration after concurrent chemoradiation therapy and consolidation osimertinib.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We report an 83-year-old woman who developed acute dyspnea and complete right-lung atelectasis 3 months after completion of concurrent chemoradiation therapy while receiving consolidation osimertinib. Bronchoscopy showed membranous occlusion of all three right lobar bronchi, and biopsy demonstrated dense collagenous tissue admixed with fibrin and mild inflammation. Systemic glucocorticoid therapy and temporary interruption of osimertinib led to initial clinical improvement, but the obliteration recurred during corticosteroid tapering.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Compared with previously reported cases, our case demonstrated a more advanced fibrotic process, together with extensive involvement of all three right lobar bronchi within the irradiated field. Notably, this fibrotic change developed earlier than is typical for radiation-induced fibrosis. While radiation-induced airway injury was the principal cause, the early onset raises the possibility that osimertinib also contributed by impairing epithelial repair through EGFR inhibition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Clinicians should be aware of the potential for collagenous endobronchial obliteration, particularly in patients with centrally located tumors receiving chemoradiation followed by consolidation osimertinib. Bronchoscopic evaluation may facilitate diagnosis, whereas systemic glucocorticoid therapy with gradual tapering and close monitoring may aid management in similar cases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1895328","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:25:14Z","timestamp":1785471914000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Collagenous endobronchial obliteration after chemoradiation followed by consolidation osimertinib: a case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Seunghun","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Korea University College of Medicine","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juwhan","family":"Choi","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baek-hui","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pathology, Korea University Guro Hospital, Korea University College of Medicine","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakyoung","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Korea University Guro Hospital, Korea University College of Medicine","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Yong","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"B1","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): non-Small Cell Lung Cancer. Version 5.2026\n          \n          2026"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2402614","article-title":"Osimertinib after chemoradiotherapy in stage III EGFR-mutated NSCLC","volume":"391","author":"Lu","year":"2024","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00877","article-title":"Radiation-induced lung injury (RILI)","volume":"9","author":"Giuranno","year":"2019","journal-title":"Front Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.14561","article-title":"Radiation-induced pseudomembranous tracheobronchitis: a report of two cases","volume":"13","author":"Choi","year":"2022","journal-title":"Thorac Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1809697","article-title":"Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC","volume":"379","author":"Antonia","year":"2018","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1103927","article-title":"Efficacy and safety of consolidation durvalumab after chemoradiation therapy for stage III non-small-cell lung cancer: a systematic review, meta-analysis, and meta-regression of real-world studies","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Pharmacol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2024.01.012","article-title":"Consolidation osimertinib versus durvalumab versus observation after concurrent chemoradiation in unresectable EGFR-mutant NSCLC: a multicenter retrospective cohort study","volume":"19","author":"Nassar","year":"2024","journal-title":"J Thorac Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.04.043","article-title":"Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis","volume":"85","author":"Palma","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.14081","article-title":"Risk factors for radiation pneumonitis and a prognostic instrument for very elderly patients with lung cancer","volume":"39","author":"Rades","year":"2025","journal-title":"In Vivo"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-2025-489","article-title":"Treatment outcomes and safety of concurrent chemoradiation in older adults with unresectable stage III non-small-cell lung cancer","volume":"17","author":"Kim","year":"2025","journal-title":"J Thorac Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2022.11.008","article-title":"The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R): real-world data on stage III non-small cell lung cancer patients treated with curative chemoradiation","volume":"24","author":"Dieleman","year":"2023","journal-title":"Clin Lung Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2020.11.006","article-title":"Biology of radiation-induced lung injury","volume":"31","author":"Roy","year":"2021","journal-title":"Semin Radiat Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/sctm.19-0278","article-title":"NOTCH inhibition promotes bronchial stem cell renewal and epithelial barrier integrity after irradiation","volume":"9","author":"Giuranno","year":"2020","journal-title":"Stem Cells Transl Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12931-025-03105-z","article-title":"Radiation decreases bronchial epithelial progenitor function as assessed by organoid formation","volume":"26","author":"Kuipers","year":"2025","journal-title":"Respir Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0360-3016(95)00095-G","article-title":"A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis","volume":"33","author":"Rubin","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-015-1974-6","article-title":"Radiation-induced fibrosis: mechanisms and implications for therapy","volume":"141","author":"Straub","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-020-01376-4","article-title":"Radiation-induced lung injury: current evidence","volume":"21","author":"Arroyo-Hernandez","year":"2021","journal-title":"BMC Pulm Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2016.12.004","article-title":"Radiation pneumonitis","volume":"38","author":"Bledsoe","year":"2017","journal-title":"Clin Chest Med"},{"key":"B19","article-title":"Epidermal growth factor receptor tyrosine kinase inhibition augments a murine model of pulmonary fibrosis","volume":"63","author":"Suzuki","year":"2003","journal-title":"Cancer Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109560","article-title":"Advances in pathogenic mechanisms and management of radiation-induced fibrosis","volume":"121","author":"Wang","year":"2020","journal-title":"BioMed Pharmacother"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1950","article-title":"Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology","volume":"6","author":"Bentzen","year":"2006","journal-title":"Nat Rev Cancer"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1895328\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:25:15Z","timestamp":1785471915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1895328\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":21,"alternative-id":["10.3389\/fonc.2026.1895328"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1895328","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"article-number":"1895328"}}